Finance

Beta
Lists
300194:SHE
Fuan Pharmaceutical Group Co Ltd
CN¥3.61
-0.28%
(-0.0100) 1D
Jun 15, 1:35:40 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300194...
Open
CN¥3.63
High
CN¥3.67
Low
CN¥3.59
Mkt. cap
4.31B
Avg. vol.
8.99M
Volume
5.64M
Dividend
1.94%
Quarterly dividend
CN¥0.02
Ex-dividend date
May 28, 2026
P/E ratio
68.32
52-wk high
CN¥5.48
52-wk low
CN¥3.46
EPS
CN¥0.05
Shares outstanding
1.19B
No. of employees
3K
Open
CN¥3.63
High
CN¥3.67
Low
CN¥3.59
Mkt. cap
4.31B
Avg. vol.
8.99M
Volume
5.64M
Dividend
1.94%
Quarterly dividend
CN¥0.02
Ex-dividend date
May 28, 2026
P/E ratio
68.32
52-wk high
CN¥5.48
52-wk low
CN¥3.46
EPS
CN¥0.05
Shares outstanding
1.19B
No. of employees
3K
News stories
From sources across the web
About Fuan Pharmaceutical Group Co Ltd
CEO-
Employees2.99K
FoundedFeb 25, 2004
Headquarters-
SectorPharmaceutical industry
Websitefapharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
452.83M
394.87M
422.92M
407.49M
Cost of goods sold
314.99M
240.79M
297.74M
242.14M
Cost of revenue
314.99M
240.79M
297.74M
242.14M
Research and development expenses
32.18M
40.41M
31.74M
26.09M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
89.87M
100.86M
98.27M
96.78M
Operating expense
131.70M
148.55M
124.59M
129.97M
Total operating expenses
446.70M
389.35M
422.33M
372.11M
Operating income
6.13M
5.52M
592.72K
35.38M
Other non operating income
3.08M
140.02K
-5.85M
-820.50K
EBT including unusual items
45.92M
49.47M
-84.64M
58.91M
EBT excluding unusual items
36.33M
46.95M
37.36M
53.83M
Income tax expense
1.98M
-3.66M
4.74M
4.14M
Effective tax rate
4.31%
-7.39%
-5.61%
7.02%
Other operating expenses
4.97M
10.64M
-6.54M
6.39M
Net income
44.07M
53.14M
-89.27M
54.92M
Net profit margin
9.73%
13.46%
-21.11%
13.48%
Earnings per share
-
-
-
-
Interest and investment income
36.07M
47.51M
47.48M
23.21M
Interest expense
-9.38M
-5.80M
-5.06M
-3.93M
Net interest expenses
26.69M
41.71M
42.42M
19.27M
Depreciation and amortization charges
-
-
-
-
EBITDA
57.13M
54.79M
51.56M
86.34M
Gain or loss from assets sale
35.99K
-35.99K
-266.14K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer